Publications Office of the EU
Supply of oncological medicines for the Zofia Zamoyskie Tarnowska Provincial Hospital in Tarnobrzeg - EU tenders
DisplayCustomHeader
MyPortal
Language Selector
English
BasketSummary
Procurement Detail Actions Portlet

Utilities

Procurement Detail Actions Portlet
OP Portal - Procurement - Details

This page contains content generated automatically to improve findability and accessibility

- indicates text translated automatically in your browsing language

Supply of oncological medicines for the Zofia Zamoyskie Tarnowska Provincial Hospital in Tarnobrzeg

Overview
  • Published
    07/10/2025
  • Deadline
    12/11/2025
  • Opening of tenders
    12/11/2025
  • Awarded
    09/02/2026
  • Today
    18/05/2026
Status
Awarded
Type of contract
Supplies
Subject for Renewal
No
Buyer
Wojewódzki Szpital im. Zofii z Zamoyskich Tarnowskiej w Tarnobrzegu
Place of performance
NUTS code: Multiple place of performance
Location of buyer
NUTS code: PL824 Tarnobrzeski
Business sector (Main CPV)
33652100 Antineoplastic agents
Total estimated contract value (excluding VAT)
Not available
Total final contract value (excluding VAT)
4,062,152.00 PLN
Number of lots
10
Procedure details
Tender reference number
WSz-II.4.291.83.2025
Description

I. Subject of the contract: The subject of the contract is the supply of oncological medicines for the Zofia Provincial Hospital of Zamoyskie Tarnowska in Tarnobrzeg, included in 10 packages. II. Description of the subject of the contract: 1. CPV code according to the Common Procurement Vocabulary: 33652100-6 Anticancer agents 2. A detailed description of the subject-matter of the contract is contained in Annex 2 to the FTZ – Price form. 3. The trade names given in the price form are examples. The contracting authority allows for the possibility of submitting equivalent tenders, i.e. equivalent pharmaceutical and therapeutic tenders. Basic concepts and definitions on bioequivalence issues of medicines; modified according to Kalishan and Janicki. Pharmaceutical equivalence defines a situation in which the medicines compared contain the same amount of a medicinal product in the same (or substantially similar - e.g. tablets, capsules) form of the drug, corresponding to the same comparable standards and intended to be administered by the same route; pharmaceutical equivalence does not determine therapeutic equivalence, since differences in the range of complementary substances and the manufacturing process may cause differences in dissolution and bioavailability and, consequently, in the action of the pharmaceutical product. Therapeutic equivalence Two agents are therapeutically equivalent if they are pharmaceutically equivalent and if, when administered at the same dose, their effects on both efficacy and safety are as could be expected from the relevant studies. 4. The rules for carrying out the supply in question are set out in the ‘Draft Contract’, which is attached as Annex 8 to the FTZ.

Submission Method
Electronic via:
https://portal.smartpzp.pl/pcmrzeszow
Tenders may be submitted
Electronic submission: required
https://portal.smartpzp.pl/pcmrzeszow
Information about a public contract, a framework agreement or a dynamic purchasing system (DPS)
Not available
Conditions for opening tenders (date)
12/11/2025 10:05
Place of performance
PL824 Tarnobrzeski
PL Polska
CPV code

33652100 - Antineoplastic agents

Lots (10)
Documents
Prior information
Contract
Award
Footnote - legal notice

This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.